Investcorp has exited its investment in the publicly listed Safari Industries, while IndiaRF is acquiring the API and contract research and manufacturing services businesses of drug firm Ind-Swift Laboratories.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
